Extended Physiotherapy After Intensive Care Unit (ICU) Stay
Extended Physiotherapy After Intensive Care Unit (ICU) Stay: A Prospective Before and After Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 11883
- Stockholm South General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age over 18 years
- ICU stay >48 hours
- Understand the Swedish language
Exclusion Criteria:
• Patients palliative care with no intention of rehabilitation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Standard amount of physical therapy at surgical wards in an urban hospital, corresponding to 1.75 physiotherapy employment on weekdays divided on four wards with a total of approx.
40-48 patients.
|
|
|
Experimental: Intervention
Extended physiotherapy with an extra 0.5 employment on weekdays, leading to 1-2 physiotherapy session per day for the study participants in the intervention group.
|
At admission to the surgical ward after ICU care, participants received an individual rehabilitation plan developed in collaboration with the participants and the ward-based physiotherapist.
The rehabilitation plan included specified exercises for 1- 2 sessions of approximately 30 minutes a day.
For example breathing exercises, practicing transfer in and out of bed and from sitting to standing, stairclimbing, and walking with or without walking aids.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in physical function according to Chelsea Critical Care Physical Assessment tool (CPAx)
Time Frame: Through study completion, an average of 2 weeks per participant
|
Measures physical function in critically ill patients
|
Through study completion, an average of 2 weeks per participant
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of intervention
Time Frame: Through study completion, an average of 2 weeks per participant
|
Number of planned interventions not delivered, and number of safety events.
|
Through study completion, an average of 2 weeks per participant
|
|
Length of stay at the ward
Time Frame: Through study completion, an average of 2 weeks per participant
|
Number of days at the hospital ward after ICU discharge
|
Through study completion, an average of 2 weeks per participant
|
|
Readmission to ICU
Time Frame: Through study completion, an average of 2 weeks per participant
|
Number of readmissions to ICU from ward, within each study group
|
Through study completion, an average of 2 weeks per participant
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Katinka Siesage, Stockholm South General Hospital
- Principal Investigator: Eva Alm- Joelsson, Stockholm South General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Improvement project AFE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.